These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23706089)

  • 1. Dengue-specific subviral nanoparticles: design, creation and characterization.
    Khetarpal N; Poddar A; Nemani SK; Dhar N; Patil A; Negi P; Perween A; Viswanathan R; Lünsdorf H; Tyagi P; Raut R; Arora U; Jain SK; Rinas U; Swaminathan S; Khanna N
    J Nanobiotechnology; 2013 May; 11():15. PubMed ID: 23706089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
    Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    J Nanobiotechnology; 2012 Jul; 10():30. PubMed ID: 22794664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design.
    Li XQ; Qiu LW; Chen Y; Wen K; Cai JP; Chen J; Pan YX; Li J; Hu DM; Huang YF; Liu LD; Ding XX; Guo YH; Che XY
    J Gen Virol; 2013 Oct; 94(Pt 10):2191-2201. PubMed ID: 23851440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4
    Zaneti AB; Yamamoto MM; Sulczewski FB; Almeida BDS; Souza HFS; Ferreira NS; Maeda DLNF; Sales NS; Rosa DS; Ferreira LCS; Boscardin SB
    Front Immunol; 2019; 10():59. PubMed ID: 30761131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shukla R; Rajpoot RK; Arora U; Poddar A; Swaminathan S; Khanna N
    Front Microbiol; 2017; 8():2644. PubMed ID: 29367852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
    Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
    Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal single-chain antibodies specific to dengue virus envelope protein.
    Saokaew N; Poungpair O; Panya A; Tarasuk M; Sawasdee N; Limjindaporn T; Chaicumpa W; Yenchitsomanus P
    Lett Appl Microbiol; 2014 Mar; 58(3):270-7. PubMed ID: 24266517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation.
    Shanmugam RK; Ramasamy V; Shukla R; Arora U; Swaminathan S; Khanna N
    Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31093663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an in vitro model.
    Nantachit N; Sunintaboon P; Ubol S
    Microbiol Immunol; 2017 Aug; 61(8):305-317. PubMed ID: 28603864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli.
    Yang J; Zhang J; Chen W; Hu Z; Zhu J; Fang X; Yuan W; Li M; Hu X; Tan Y; Hu F; Rao X
    Can J Microbiol; 2012 Apr; 58(4):369-80. PubMed ID: 22420529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural strain variation and antibody neutralization of dengue serotype 3 viruses.
    Wahala WM; Donaldson EF; de Alwis R; Accavitti-Loper MA; Baric RS; de Silva AM
    PLoS Pathog; 2010 Mar; 6(3):e1000821. PubMed ID: 20333252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of dengue virus envelope protein domain III-based antigens in tobacco chloroplasts using inducible and constitutive expression systems.
    Gottschamel J; Lössl A; Ruf S; Wang Y; Skaugen M; Bock R; Clarke JL
    Plant Mol Biol; 2016 Jul; 91(4-5):497-512. PubMed ID: 27116001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice.
    Rajpoot RK; Shukla R; Arora U; Swaminathan S; Khanna N
    Sci Rep; 2018 Jun; 8(1):8643. PubMed ID: 29872153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.
    Kaushik N; Rohila D; Arora U; Raut R; Lamminmäki U; Khanna N; Batra G
    BMC Biotechnol; 2016 Feb; 16():12. PubMed ID: 26847361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
    Mani S; Tripathi L; Raut R; Tyagi P; Arora U; Barman T; Sood R; Galav A; Wahala W; de Silva A; Swaminathan S; Khanna N
    PLoS One; 2013; 8(5):e64595. PubMed ID: 23717637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
    Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
    Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.